Patient Selection Markers for Anti-angiogenic Agents in Metastatic Renal Cell Carcinoma: Dream or Reality? Proffered Paper Session
Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients Platelets and vascular endothelium
On the use of anti-platelet drugs to diminish both tumor growth and thrombosis Platelets and vascular endothelium
New antithrombotic agents in the treatment of VTE; a subgroup analysis of the Phase III randomized clinical trials Anticoagulants and cancer
New potential markers of severe thrombo-hemorrhagic syndrome (THS) in acute promyelocytic leukemia (APL) patients: activated FVII-antithrombin complex (FVIIa-AT) and Tissue Factor (TF) mRNA Hematological disorders